ScholarIQanswers from OpenAlex & ORCID
Takeshi Kato
ResearcherPublications, citations & collaboration network
Takeshi Kato is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Takeshi Kato have?
ScholarIQindexed works
Takeshi Kato has 665 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Takeshi Kato have?
ScholarIQcitation count
Takeshi Kato has 8,337 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Takeshi Kato?
ScholarIQh-index
Takeshi Kato has an h-index of 49 in OpenAlex.
What is the i10-index of Takeshi Kato?
ScholarIQi10-index
Takeshi Kato has an i10-index of 149 in OpenAlex.
What is the ORCID of Takeshi Kato?
ScholarIQorcid
The ORCID for Takeshi Kato is on the source record.
What is the OpenAlex record for Takeshi Kato?
ScholarIQopenalex
The OpenAlex for Takeshi Kato is on the source record.
What are the most-cited papers on Takeshi Kato?
ScholarIQmost cited works
Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer
Daisuke Kotani, Eiji Oki, Yoshiaki Nakamura, Hiroki Yukami, Saori Mishima, Hideaki Bando, Hiromichi Shirasu, Kentaro Yamazaki, Jun Watanabe, Masahito Kotaka, Keiji Hirata, Naoya Akazawa, Kozo Kataoka, Shruti Sharma, Vasily N. Aushev, Alexey Aleshin, Toshihiro Misumi, Hiroya Taniguchi, Ichiro Takemasa, Takeshi Kato, Masaki Mori, Takayuki Yoshino
Clinical utility of circulating tumor DNA sequencing in advanced gastrointestinal cancer: SCRUM-Japan GI-SCREEN and GOZILA studies
Yoshiaki Nakamura, Hiroya Taniguchi, Masafumi Ikeda, Hideaki Bando, Ken Kato, Chigusa Morizane, Taito Esaki, Yoshito Komatsu, Yasuyuki Kawamoto, Naoki Takahashi, Makoto Ueno, Yoshinori Kagawa, Tomohiro Nishina, Takeshi Kato, Yoshiyuki Yamamoto, Junji Furuse, Tadamichi Denda, Hisato Kawakami, Eiji Oki, Takako Eguchi Nakajima, Naohiro Nishida, Kensei Yamaguchi, Hisateru Yasui, Masahiro Goto, Nobuhisa Matsuhashi, Koushiro Ohtsubo, Kentaro Yamazaki, Akihito Tsuji, Wataru Okamoto, Katsuya Tsuchihara, Takeharu Yamanaka, Miki Izumi, Yasutoshi Sakamoto, Hiroko Ichiki, Masayuki Hata, Riu Yamashita, Atsushi Ohtsu, Justin I. Odegaard, Takayuki Yoshino
Panitumumab vs Bevacizumab Added to Standard First-line Chemotherapy and Overall Survival Among Patients With <i>RAS</i> Wild-type, Left-Sided Metastatic Colorectal Cancer
Jun Watanabe, Kei Muro, Kohei Shitara, Kentaro Yamazaki, Manabu Shiozawa, Hisatsugu Ohori, Atsuo Takashima, Mitsuru Yokota, Akitaka Makiyama, Naoya Akazawa, Hitoshi Ojima, Yasuhiro Yuasa, Keisuke Miwa, Hirofumi Yasui, Eiji Oki, Takeo Sato, Takeshi Naitoh, Yoshito Komatsu, Takeshi Kato, Masamitsu Hihara, Junpei Soeda, Toshihiro Misumi, Kouji Yamamoto, Kiwamu Akagi, Atsushi Ochiai, Hiroyuki Uetake, Katsuya Tsuchihara, Takayuki Yoshino
Circulating tumor DNA-guided treatment with pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer: a phase 2 trial
Yoshiaki Nakamura, Wataru Okamoto, Takeshi Kato, Taito Esaki, Ken Kato, Yoshito Komatsu, Satoshi Yuki, Toshiki Masuishi, Tomohiro Nishina, Hiromichi Ebi, Kentaro Sawada, Hiroya Taniguchi, Nozomu Fuse, Shogo Nomura, Makoto Fukui, Seiko Matsuda, Yasutoshi Sakamoto, Hiroshi Uchigata, Kana Kitajima, Naomi Kuramoto, T. Asakawa, Steve Olsen, Justin I. Odegaard, Akihiro Sato, Satoshi Fujii, Atsushi Ohtsu, Takayuki Yoshino
Highly sensitive assay for tyrosine hydroxylase activity by high-performance liquid chromatography
Toshiharu Nagatsu, Kazuhiro Oka, Takeshi Kato